Associations of MEFV gene variants, IL-33, and sST2 with the risk of Henoch-Schönlein purpura in children

Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene (MEFV) variants in HSP remains controversial. The objective of this study was...

Full description

Saved in:
Bibliographic Details
Published inHeliyon Vol. 10; no. 8; p. e29469
Main Authors Ruan, Yang, Xie, Longlong
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 30.04.2024
Elsevier
Subjects
Online AccessGet full text
ISSN2405-8440
2405-8440
DOI10.1016/j.heliyon.2024.e29469

Cover

Abstract Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene (MEFV) variants in HSP remains controversial. The objective of this study was to evaluate relationships between MEFV variants and susceptibility to HSP and their associations with clinical outcomes. We also investigated levels of IL-33 and soluble suppression of tumorigenicity 2 (sST2) in children with HSP and their clinical significance. We selected 100 children with HSP as the case group. The control group consisted of 50 children who visited the hospital for physical health examinations. All subjects were screened for MEFV gene exon mutations, and levels of IL-33 and sST2 were measured. The frequency of MEFV variants was significantly greater in HSP patients than in healthy controls. The variant with the highest frequency was E148Q. The frequency of the C allele of the MEFV variant E148Q was 32 % in HSP patients and 18 % in controls (P-adjust = 0.04). Patients with the MEFV E148Q variant had more frequent joint involvement and recurrent purpura and higher levels of IL-33 and C-reactive protein (CRP). Levels of IL-33 and sST2 in children with HSP were significantly higher than those in the control group, and the sST2/IL-33 ratio in children with HSP was unbalanced (P-adjust <0.05). Logistic regression analysis revealed the presence of E148Q and an unbalanced sST2/IL-33 ratio to be independent risk factors for HSP. The results of this study suggest that the MEFV variant E148Q is associated with HSP susceptibility in Chinese children and that carriers of the variant may have more severe clinical manifestations and greater inflammatory responses. E148Q and the sST2/IL-33 ratio may play important roles in the pathogenesis of HSP.
AbstractList Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene ( ) variants in HSP remains controversial. The objective of this study was to evaluate relationships between variants and susceptibility to HSP and their associations with clinical outcomes. We also investigated levels of IL-33 and soluble suppression of tumorigenicity 2 (sST2) in children with HSP and their clinical significance. We selected 100 children with HSP as the case group. The control group consisted of 50 children who visited the hospital for physical health examinations. All subjects were screened for gene exon mutations, and levels of IL-33 and sST2 were measured. The frequency of variants was significantly greater in HSP patients than in healthy controls. The variant with the highest frequency was E148Q. The frequency of the C allele of the variant E148Q was 32 % in HSP patients and 18 % in controls ( adjust = 0.04). Patients with the E148Q variant had more frequent joint involvement and recurrent purpura and higher levels of IL-33 and C-reactive protein (CRP). Levels of IL-33 and sST2 in children with HSP were significantly higher than those in the control group, and the sST2/IL-33 ratio in children with HSP was unbalanced ( adjust <0.05). Logistic regression analysis revealed the presence of E148Q and an unbalanced sST2/IL-33 ratio to be independent risk factors for HSP. The results of this study suggest that the variant E148Q is associated with HSP susceptibility in Chinese children and that carriers of the variant may have more severe clinical manifestations and greater inflammatory responses. E148Q and the sST2/IL-33 ratio may play important roles in the pathogenesis of HSP.
Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene (MEFV) variants in HSP remains controversial. The objective of this study was to evaluate relationships between MEFV variants and susceptibility to HSP and their associations with clinical outcomes. We also investigated levels of IL-33 and soluble suppression of tumorigenicity 2 (sST2) in children with HSP and their clinical significance. We selected 100 children with HSP as the case group. The control group consisted of 50 children who visited the hospital for physical health examinations. All subjects were screened for MEFV gene exon mutations, and levels of IL-33 and sST2 were measured. The frequency of MEFV variants was significantly greater in HSP patients than in healthy controls. The variant with the highest frequency was E148Q. The frequency of the C allele of the MEFV variant E148Q was 32 % in HSP patients and 18 % in controls (P-adjust = 0.04). Patients with the MEFV E148Q variant had more frequent joint involvement and recurrent purpura and higher levels of IL-33 and C-reactive protein (CRP). Levels of IL-33 and sST2 in children with HSP were significantly higher than those in the control group, and the sST2/IL-33 ratio in children with HSP was unbalanced (P-adjust <0.05). Logistic regression analysis revealed the presence of E148Q and an unbalanced sST2/IL-33 ratio to be independent risk factors for HSP. The results of this study suggest that the MEFV variant E148Q is associated with HSP susceptibility in Chinese children and that carriers of the variant may have more severe clinical manifestations and greater inflammatory responses. E148Q and the sST2/IL-33 ratio may play important roles in the pathogenesis of HSP.
Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene (MEFV) variants in HSP remains controversial. The objective of this study was to evaluate relationships between MEFV variants and susceptibility to HSP and their associations with clinical outcomes. We also investigated levels of IL-33 and soluble suppression of tumorigenicity 2 (sST2) in children with HSP and their clinical significance. We selected 100 children with HSP as the case group. The control group consisted of 50 children who visited the hospital for physical health examinations. All subjects were screened for MEFV gene exon mutations, and levels of IL-33 and sST2 were measured. The frequency of MEFV variants was significantly greater in HSP patients than in healthy controls. The variant with the highest frequency was E148Q. The frequency of the C allele of the MEFV variant E148Q was 32 % in HSP patients and 18 % in controls (P-adjust = 0.04). Patients with the MEFV E148Q variant had more frequent joint involvement and recurrent purpura and higher levels of IL-33 and C-reactive protein (CRP). Levels of IL-33 and sST2 in children with HSP were significantly higher than those in the control group, and the sST2/IL-33 ratio in children with HSP was unbalanced (P-adjust <0.05). Logistic regression analysis revealed the presence of E148Q and an unbalanced sST2/IL-33 ratio to be independent risk factors for HSP. The results of this study suggest that the MEFV variant E148Q is associated with HSP susceptibility in Chinese children and that carriers of the variant may have more severe clinical manifestations and greater inflammatory responses. E148Q and the sST2/IL-33 ratio may play important roles in the pathogenesis of HSP.
Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene (MEFV) variants in HSP remains controversial. The objective of this study was to evaluate relationships between MEFV variants and susceptibility to HSP and their associations with clinical outcomes. We also investigated levels of IL-33 and soluble suppression of tumorigenicity 2 (sST2) in children with HSP and their clinical significance.ObjectiveHenoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene (MEFV) variants in HSP remains controversial. The objective of this study was to evaluate relationships between MEFV variants and susceptibility to HSP and their associations with clinical outcomes. We also investigated levels of IL-33 and soluble suppression of tumorigenicity 2 (sST2) in children with HSP and their clinical significance.We selected 100 children with HSP as the case group. The control group consisted of 50 children who visited the hospital for physical health examinations. All subjects were screened for MEFV gene exon mutations, and levels of IL-33 and sST2 were measured.MethodsWe selected 100 children with HSP as the case group. The control group consisted of 50 children who visited the hospital for physical health examinations. All subjects were screened for MEFV gene exon mutations, and levels of IL-33 and sST2 were measured.The frequency of MEFV variants was significantly greater in HSP patients than in healthy controls. The variant with the highest frequency was E148Q. The frequency of the C allele of the MEFV variant E148Q was 32 % in HSP patients and 18 % in controls (P-adjust = 0.04). Patients with the MEFV E148Q variant had more frequent joint involvement and recurrent purpura and higher levels of IL-33 and C-reactive protein (CRP). Levels of IL-33 and sST2 in children with HSP were significantly higher than those in the control group, and the sST2/IL-33 ratio in children with HSP was unbalanced (P-adjust <0.05). Logistic regression analysis revealed the presence of E148Q and an unbalanced sST2/IL-33 ratio to be independent risk factors for HSP.ResultsThe frequency of MEFV variants was significantly greater in HSP patients than in healthy controls. The variant with the highest frequency was E148Q. The frequency of the C allele of the MEFV variant E148Q was 32 % in HSP patients and 18 % in controls (P-adjust = 0.04). Patients with the MEFV E148Q variant had more frequent joint involvement and recurrent purpura and higher levels of IL-33 and C-reactive protein (CRP). Levels of IL-33 and sST2 in children with HSP were significantly higher than those in the control group, and the sST2/IL-33 ratio in children with HSP was unbalanced (P-adjust <0.05). Logistic regression analysis revealed the presence of E148Q and an unbalanced sST2/IL-33 ratio to be independent risk factors for HSP.The results of this study suggest that the MEFV variant E148Q is associated with HSP susceptibility in Chinese children and that carriers of the variant may have more severe clinical manifestations and greater inflammatory responses. E148Q and the sST2/IL-33 ratio may play important roles in the pathogenesis of HSP.ConclusionThe results of this study suggest that the MEFV variant E148Q is associated with HSP susceptibility in Chinese children and that carriers of the variant may have more severe clinical manifestations and greater inflammatory responses. E148Q and the sST2/IL-33 ratio may play important roles in the pathogenesis of HSP.
Objective: Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still unclear. The pathogenicity of familial Mediterranean fever gene (MEFV) variants in HSP remains controversial. The objective of this study was to evaluate relationships between MEFV variants and susceptibility to HSP and their associations with clinical outcomes. We also investigated levels of IL-33 and soluble suppression of tumorigenicity 2 (sST2) in children with HSP and their clinical significance. Methods: We selected 100 children with HSP as the case group. The control group consisted of 50 children who visited the hospital for physical health examinations. All subjects were screened for MEFV gene exon mutations, and levels of IL-33 and sST2 were measured. Results: The frequency of MEFV variants was significantly greater in HSP patients than in healthy controls. The variant with the highest frequency was E148Q. The frequency of the C allele of the MEFV variant E148Q was 32 % in HSP patients and 18 % in controls (P-adjust = 0.04). Patients with the MEFV E148Q variant had more frequent joint involvement and recurrent purpura and higher levels of IL-33 and C-reactive protein (CRP). Levels of IL-33 and sST2 in children with HSP were significantly higher than those in the control group, and the sST2/IL-33 ratio in children with HSP was unbalanced (P-adjust <0.05). Logistic regression analysis revealed the presence of E148Q and an unbalanced sST2/IL-33 ratio to be independent risk factors for HSP. Conclusion: The results of this study suggest that the MEFV variant E148Q is associated with HSP susceptibility in Chinese children and that carriers of the variant may have more severe clinical manifestations and greater inflammatory responses. E148Q and the sST2/IL-33 ratio may play important roles in the pathogenesis of HSP.
ArticleNumber e29469
Author Ruan, Yang
Xie, Longlong
Author_xml – sequence: 1
  givenname: Yang
  surname: Ruan
  fullname: Ruan, Yang
  organization: Department of Laboratory Medicine, The Affiliated Children's Hospital Of Xiangya School of Medicine, Central South University (Hunan Children’s Hospital) , Changsha, 410007, China
– sequence: 2
  givenname: Longlong
  orcidid: 0000-0002-5690-9083
  surname: Xie
  fullname: Xie, Longlong
  email: xielonglong@hnetyy.net
  organization: Pediatrics Research Institute of Hunan Province, The Affiliated Children's Hospital Of Xiangya School of Medicine, Central South University(Hunan Children’s Hospital) , Changsha, 410007, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38655333$$D View this record in MEDLINE/PubMed
BookMark eNqFks1uGyEQx1dVquajeYRWHHvIurDAspyqKMqHJVc9JO0VsTB4cdfgwtpRXqwv0BfrOnbT5BQJaUbMn5-Gmf9xcRBigKL4QPCEYFJ_Xkw66P1DDJMKV2wClWS1fFMcVQzzsmEMHzzLD4vTnBcYY8KbWgr6rjikTc05pfSoWJznHI3Xg48ho-jQ18urH2gOAdBGJ6_DkM_QdFZSeoZ0sCjf3lXo3g8dGjpAyeef20c3EKLpylvT_fkdevABrdZpPBqNqel8bxOE98Vbp_sMp_t4Uny_ury7uCln366nF-ez0jCKZSml5NZycKwimFMtDGeiscY6qiUhQteYCVcxoa2oLUhnaduaylrmaCuhpSfFdMe1US_UKvmlTg8qaq8eL2KaK50Gb3pQEjcjlwhZGcMq56RoeaPHSGzjamtH1pcda7Vul2ANhCHp_gX0ZSX4Ts3jRhGCaY0xHQmf9oQUf60hD2rps4G-1wHiOitKOG0oI4y8LsWs5kSIR-rH5309NfRvsaOA7wQmxZwTuCcJwWrrIbVQew-prYfUzkP_PwzjhjYeksrGQzBgfQIzjCP0rxD-Ahvh0ng
Cites_doi 10.1038/ng1101-241
10.1038/sj.ejhg.5200608
10.1007/s00296-016-3596-y
10.3906/sag-1505-131
10.1016/j.jhep.2012.03.035
10.1136/ard.2009.122655
10.3390/ijms22147538
10.1038/s41419-021-04159-9
10.1038/ng0997-25
10.1016/j.autrev.2017.10.009
10.1159/000185813
10.1073/pnas.1601914113
10.1007/s00403-012-1268-7
10.1016/j.freeradbiomed.2023.03.024
10.1073/pnas.1418549112
10.1067/S0022-3476(03)00502-X
10.1016/j.cca.2020.04.011
10.2310/JIM.0b013e31826d8fcb
10.3899/jrheum.080405
10.1007/s00296-011-2266-3
10.1016/j.immuni.2005.09.015
10.1007/s00467-010-1582-2
10.3389/fimmu.2012.00082
10.1172/jci.insight.172975
10.21037/apm-21-1227
10.1111/1756-185X.12072
10.4049/jimmunol.0802387
10.1189/jlb.3RU0115-012R
10.1016/j.immuni.2015.06.006
10.1016/j.cytogfr.2015.07.017
10.1182/blood-2009-02-203372
10.1111/j.1651-2227.2011.02143.x
10.1136/ard.2005.046300
10.1002/art.40375
10.3899/jrheum.140234
10.1007/s10067-019-04489-2
10.1186/1546-0096-12-41
10.1186/s13075-014-0439-7
10.1186/s12887-019-1802-2
10.1038/nri2692
10.1136/annrheumdis-2011-200589
10.3899/jrheum.100184
10.1080/00325481.2019.1552479
10.1371/journal.pone.0188718
10.1007/s00281-021-00874-9
10.1155/2014/423957
10.1146/annurev.immunol.021908.132612
10.1016/j.jaut.2019.06.010
10.1136/annrheumdis-2012-203187
10.3390/molecules23071665
10.1016/j.cytogfr.2019.04.004
10.1016/j.jaci.2018.01.034
10.1016/j.cytogfr.2017.09.005
10.1007/s00296-011-1840-z
10.1016/j.jbspin.2008.09.011
10.1002/(SICI)1098-1004(200004)15:4<385::AID-HUMU22>3.0.CO;2-A
10.3389/fimmu.2018.02004
ContentType Journal Article
Copyright 2024 The Authors
2024 The Authors.
2024 The Authors 2024
Copyright_xml – notice: 2024 The Authors
– notice: 2024 The Authors.
– notice: 2024 The Authors 2024
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
7S9
L.6
5PM
DOA
DOI 10.1016/j.heliyon.2024.e29469
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList PubMed

AGRICOLA
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2405-8440
ExternalDocumentID oai_doaj_org_article_908cdf1792cc42ff97b58aff91d8f6dd
PMC11036003
38655333
10_1016_j_heliyon_2024_e29469
S2405844024055002
Genre Journal Article
GroupedDBID 0R~
457
53G
5VS
6I.
AAEDW
AAFTH
AAFWJ
AALRI
AAYWO
ABMAC
ACGFS
ACLIJ
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AEUPX
AEXQZ
AFJKZ
AFPKN
AFPUW
AFTJW
AGHFR
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BAWUL
BCNDV
DIK
EBS
FDB
GROUPED_DOAJ
HYE
KQ8
M~E
O9-
OK1
ROL
RPM
SSZ
AAYXX
CITATION
EJD
IPNFZ
RIG
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c4309-9995dd5ef421053a7c5478dcdf3a9117a6047f247ad76de9fd3bbc2dd4f3b9eb3
IEDL.DBID DOA
ISSN 2405-8440
IngestDate Wed Aug 27 01:31:53 EDT 2025
Thu Aug 21 18:34:48 EDT 2025
Fri Aug 22 20:24:35 EDT 2025
Fri Jul 11 00:14:56 EDT 2025
Mon Jul 21 05:57:13 EDT 2025
Thu Jul 24 01:53:55 EDT 2025
Sat Aug 16 17:01:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Henoch-Schönlein purpura
Children
Soluble ST2
MEFV
Interleukin-33
Language English
License This is an open access article under the CC BY-NC-ND license.
2024 The Authors.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4309-9995dd5ef421053a7c5478dcdf3a9117a6047f247ad76de9fd3bbc2dd4f3b9eb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5690-9083
OpenAccessLink https://doaj.org/article/908cdf1792cc42ff97b58aff91d8f6dd
PMID 38655333
PQID 3046517703
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_908cdf1792cc42ff97b58aff91d8f6dd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11036003
proquest_miscellaneous_3153834141
proquest_miscellaneous_3046517703
pubmed_primary_38655333
crossref_primary_10_1016_j_heliyon_2024_e29469
elsevier_sciencedirect_doi_10_1016_j_heliyon_2024_e29469
PublicationCentury 2000
PublicationDate 2024-04-30
PublicationDateYYYYMMDD 2024-04-30
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-30
  day: 30
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Heliyon
PublicationTitleAlternate Heliyon
PublicationYear 2024
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Li, Li, Wang, Yang, Zu (bib8) 2012; 32
Molofsky, Savage, Locksley (bib14) 2015; 42
Durmus, Alayli, Cengiz, Yigit, Canturk, Bagci (bib35) 2009; 76
Kastner, O'Shea (bib5) 2001; 29
Aksu, Keser (bib6) 2011; 31
Montoliu, Lens, Torras, Revert (bib2) 1990; 54
Gershoni-Baruch, Broza, Brik (bib37) 2003; 143
Heineke, Ballering, Jamin, Mkaddem, Monteiro, Egmond (bib27) 2017; 16
Livneh, Aksentijevich, Langevitz, Torosyan, G-Shoham, Shinar, Pras, Zaks, Padeh, Kastner, Pras (bib41) 2001; 9
Baumann, Bonilla, Fröhlich, Helmstetter, Peine, Hegazy, Pinschewer, Löhning (bib53) 2015; 112
Lunderius-Andersson, Enoksson, Nilsson (bib48) 2012; 3
Szabo, Csak (bib11) 2012; 57
Wang, Zheng, Chen, Lv, Lian, Jiang, Ke, Liu, Fan, Gong (bib13) 2021; 10
Ekinci, Balci, Bisgin, Atmis, DogruelAltintas, Altintas, Yilmaz (bib28) 2019; 131
Can, Yaprak, Hamilçıkan, Erol, Y Özgül Yiğit (bib32) 2018; 116
De la Fuente, MacDonald, Hermoso (bib50) 2015; 26
Xu, Li, Wu (bib3) 2022; 13
Wang, Jin, Jian, Han, Song, Zhou, Yu (bib40) 2023; 8
Chen, Jia, Guo, Cao, Li, Jiao (bib51) 2013; 305
Liew, Pitman, McInnes (bib49) 2010; 10
Takatori, Makita, Ito, Matsuki, Nakajima (bib57) 2018; 9
Wang, Dong (bib7) 2017; 25
Nikibakhsh, Houshmand, Bagheri, Zadeh, Rad (bib36) 2012; 61
Pillebout, Sunderkötter (bib26) 2021; 43
Cakici, Kurt Sukur, Ozlu, Yazilitas, Özdel, Gür, Eroğlu, Güngör, Çelikkaya, Bağlan, Bülbül (bib29) 2019; 38
Jung, Lee, Baek, Lee, Lee, Park, Park, Kim, Kwok (bib20) 2015; 42
Zhu, Dong, Wu, Deng (bib9) 2019; 19
Saadah, Al-Harthi, Al-Mughales, Bin-Taleb, Baeshen (bib45) 2015; 8
Nunes, Bernardazzi, de Souza (bib60) 2014; 2014
Liew (bib17) 2012; 71
Ozçakar, Yalçinkaya, Cakar, Acar, Kasapçopur, Ugüten, Soy, Kara, Uncu, Arisoy, Ekim (bib21) 2008; 35
Shin, Lee, Joo, Lee, Jeon, Jung, Shin, Cho, Kim, Park, Jeon, Jeong, Lee, Kang, Oh, Lee, Lee, Kwon, Oh, Kronbichler (bib42) 2019; 103
He, Lu, Kang, Luan, Liu, Yin, Yao, Ding, Tao, Heng (bib23) 2010; 25
Zeng, Yang, Ye, Feng, Xu, Yang, Wang, Bao, Li, Xue, Zang, Huang (bib43) 2023; 202
Mu, Huang, Li, Li, Ye, Li (bib59) 2010; 37
Bonyadi, Younesi, Rafeey, Shabestari, Mortazavi (bib30) 2016; 46
Liu, Xiao, Pan, Li, Zheng, Su (bib63) 2019; 50
Schmitz, Owyang, Oldham, Song, Murphy, McClanahan, Zurawski, Moshrefi, Qin, Li, Gorman, Bazan, Kastelein (bib15) 2005; 23
Préfontaine, Lajoie-Kadoch, Foley, Audusseau, Olivenstein, Halayko, Lemière, Martin, Hamid (bib58) 2009; 183
Xiong, Xiong, Huang, Wang, Zhang (bib24) 2017; 37
Bayram, Demircin, Erdogan, Bulbul, Caltik, Akyuz (bib22) 2011; 100
Kishida, Nakamura, Yazaki, Tsuchiya-Suzuki, Matsuda, Ikeda (bib39) 2014; 16
Ben-Chetrit, Lerer, Malamud, Domingo, Abeliovich (bib33) 2000; 15
Ozen, Ruperto, Dillon, Bagga, Barron, Davin, Kawasaki, Lindsley, Petty, Prieur, Ravelli, Woo (bib25) 2006; 65
Dinarello (bib47) 2009; 27
Gordon, Simpson, Rios, Ringel, Lachowicz-Scroggins, Peters, Wesolowska-Andersen, Gonzalez, MacLeod, Christian, Yuan, Barry, Woodruff, Ansel, Nocka, Seibold, Fahy (bib55) 2016; 113
Salah, Rizk, Lotfy, Houchi, Marzouk, Farag (bib31) 2014; 12
Gupta, Gupta, Dwivedi (bib62) 2017; 12
Zheng, Yao, Zhou, Gu, Wang, Bao, Sun, Hong (bib44) 2021; 12
Verri, Souto, Vieira, Almeida, Fukada, Xu, Alves-Filho, Cunha, Guerrero, Mattos-Guimaraes, Oliveira, Teixeira, Silva, McInnes, Ferreira, Louzada-Junior, Liew, Cunha (bib46) 2010; 69
Wang, Ding, Liu, Wang, Leng, Chen, Fan, Pan, Ye (bib18) 2012; 60
Consortium (bib4) 1997; 17
Pillebout, Jamin, Ayari, Housset, Pierre, Sauvaget, Viglietti, Deschenes, C Monteiro, Berthelot (bib12) 2017; 12
Olivera, Beaven, Metcalfe (bib54) 2018; 142
Ding, Zou, Zhang, Lai, Chen, Xiong (bib56) 2018; 23
Sunderkötter, Zelger, Chen, Requena, Piette, Carlson, Dutz, Lamprecht, Mahr, Aberer, Werth, Wetter, Kawana, Luqmani, Frances, Jorizzo, Watts, Metze, Caproni, Alpsoy, Callen, Fiorentino, Merkel, Falk, Jennette (bib1) 2018; 70
Choi, Choi, Min, Pyun, Maeng, Park, Kim, Kim, Kwon (bib52) 2009; 114
Gao, Li, Li (bib61) 2015; 98
Migita, Nakamura, Maeda, Miyashita, Koga, Tanaka, Nakamura, Komori, Ishibashi, Origuchi, Ida, Kawasaki, Yasunami, Eguchi (bib34) 2008; 26
Sugino, Sawada, Nakamura (bib10) 2021; 22
Awada, Nicaise, Ena, Schandéné, Rasschaert, Popescu, Gangji, Soyfoo (bib19) 2014; 73
Homsak, Gruson (bib16) 2020; 507
Altug, Ensari, Sayin, Ensari (bib38) 2013; 16
Montoliu (10.1016/j.heliyon.2024.e29469_bib2) 1990; 54
Zhu (10.1016/j.heliyon.2024.e29469_bib9) 2019; 19
Olivera (10.1016/j.heliyon.2024.e29469_bib54) 2018; 142
Shin (10.1016/j.heliyon.2024.e29469_bib42) 2019; 103
Liew (10.1016/j.heliyon.2024.e29469_bib49) 2010; 10
Bonyadi (10.1016/j.heliyon.2024.e29469_bib30) 2016; 46
Mu (10.1016/j.heliyon.2024.e29469_bib59) 2010; 37
Consortium (10.1016/j.heliyon.2024.e29469_bib4) 1997; 17
Migita (10.1016/j.heliyon.2024.e29469_bib34) 2008; 26
Szabo (10.1016/j.heliyon.2024.e29469_bib11) 2012; 57
He (10.1016/j.heliyon.2024.e29469_bib23) 2010; 25
Salah (10.1016/j.heliyon.2024.e29469_bib31) 2014; 12
Jung (10.1016/j.heliyon.2024.e29469_bib20) 2015; 42
Livneh (10.1016/j.heliyon.2024.e29469_bib41) 2001; 9
Nunes (10.1016/j.heliyon.2024.e29469_bib60) 2014; 2014
Altug (10.1016/j.heliyon.2024.e29469_bib38) 2013; 16
Bayram (10.1016/j.heliyon.2024.e29469_bib22) 2011; 100
Gordon (10.1016/j.heliyon.2024.e29469_bib55) 2016; 113
Pillebout (10.1016/j.heliyon.2024.e29469_bib26) 2021; 43
Lunderius-Andersson (10.1016/j.heliyon.2024.e29469_bib48) 2012; 3
Sunderkötter (10.1016/j.heliyon.2024.e29469_bib1) 2018; 70
Liew (10.1016/j.heliyon.2024.e29469_bib17) 2012; 71
Durmus (10.1016/j.heliyon.2024.e29469_bib35) 2009; 76
Kishida (10.1016/j.heliyon.2024.e29469_bib39) 2014; 16
Zeng (10.1016/j.heliyon.2024.e29469_bib43) 2023; 202
Schmitz (10.1016/j.heliyon.2024.e29469_bib15) 2005; 23
Chen (10.1016/j.heliyon.2024.e29469_bib51) 2013; 305
Homsak (10.1016/j.heliyon.2024.e29469_bib16) 2020; 507
Baumann (10.1016/j.heliyon.2024.e29469_bib53) 2015; 112
Molofsky (10.1016/j.heliyon.2024.e29469_bib14) 2015; 42
Wang (10.1016/j.heliyon.2024.e29469_bib7) 2017; 25
Choi (10.1016/j.heliyon.2024.e29469_bib52) 2009; 114
Takatori (10.1016/j.heliyon.2024.e29469_bib57) 2018; 9
Wang (10.1016/j.heliyon.2024.e29469_bib13) 2021; 10
Xiong (10.1016/j.heliyon.2024.e29469_bib24) 2017; 37
Nikibakhsh (10.1016/j.heliyon.2024.e29469_bib36) 2012; 61
Saadah (10.1016/j.heliyon.2024.e29469_bib45) 2015; 8
Cakici (10.1016/j.heliyon.2024.e29469_bib29) 2019; 38
Dinarello (10.1016/j.heliyon.2024.e29469_bib47) 2009; 27
Sugino (10.1016/j.heliyon.2024.e29469_bib10) 2021; 22
Li (10.1016/j.heliyon.2024.e29469_bib8) 2012; 32
Awada (10.1016/j.heliyon.2024.e29469_bib19) 2014; 73
Gershoni-Baruch (10.1016/j.heliyon.2024.e29469_bib37) 2003; 143
Gao (10.1016/j.heliyon.2024.e29469_bib61) 2015; 98
Kastner (10.1016/j.heliyon.2024.e29469_bib5) 2001; 29
Pillebout (10.1016/j.heliyon.2024.e29469_bib12) 2017; 12
De la Fuente (10.1016/j.heliyon.2024.e29469_bib50) 2015; 26
Préfontaine (10.1016/j.heliyon.2024.e29469_bib58) 2009; 183
Gupta (10.1016/j.heliyon.2024.e29469_bib62) 2017; 12
Aksu (10.1016/j.heliyon.2024.e29469_bib6) 2011; 31
Ozçakar (10.1016/j.heliyon.2024.e29469_bib21) 2008; 35
Liu (10.1016/j.heliyon.2024.e29469_bib63) 2019; 50
Heineke (10.1016/j.heliyon.2024.e29469_bib27) 2017; 16
Can (10.1016/j.heliyon.2024.e29469_bib32) 2018; 116
Verri (10.1016/j.heliyon.2024.e29469_bib46) 2010; 69
Ding (10.1016/j.heliyon.2024.e29469_bib56) 2018; 23
Wang (10.1016/j.heliyon.2024.e29469_bib40) 2023; 8
Zheng (10.1016/j.heliyon.2024.e29469_bib44) 2021; 12
Wang (10.1016/j.heliyon.2024.e29469_bib18) 2012; 60
Ben-Chetrit (10.1016/j.heliyon.2024.e29469_bib33) 2000; 15
Xu (10.1016/j.heliyon.2024.e29469_bib3) 2022; 13
Ekinci (10.1016/j.heliyon.2024.e29469_bib28) 2019; 131
Ozen (10.1016/j.heliyon.2024.e29469_bib25) 2006; 65
References_xml – volume: 57
  start-page: 642
  year: 2012
  end-page: 654
  ident: bib11
  article-title: Inflammasomes in liver diseases
  publication-title: J. Hepatol.
– volume: 73
  start-page: 1259
  year: 2014
  end-page: 1263
  ident: bib19
  article-title: Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome
  publication-title: Ann. Rheum. Dis.
– volume: 305
  start-page: 173
  year: 2013
  end-page: 177
  ident: bib51
  article-title: Elevated serum interleukin-33 levels in patients with Henoch-Schonlein purpura
  publication-title: Arch. Dermatol. Res.
– volume: 112
  start-page: 4056
  year: 2015
  end-page: 4061
  ident: bib53
  article-title: T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 35
  start-page: 2427
  year: 2008
  end-page: 2429
  ident: bib21
  article-title: MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura
  publication-title: J. Rheumatol.
– volume: 65
  start-page: 936
  year: 2006
  end-page: 941
  ident: bib25
  article-title: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides
  publication-title: Annals of the rheumatic dieases
– volume: 100
  start-page: 745
  year: 2011
  end-page: 749
  ident: bib22
  article-title: Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Schönlein purpura
  publication-title: Acta. Pediatr.
– volume: 507
  start-page: 75
  year: 2020
  end-page: 87
  ident: bib16
  article-title: Soluble ST2: a complex and diverse role in several diseases
  publication-title: Clin. Chim. Acta
– volume: 42
  start-page: 264
  year: 2015
  end-page: 271
  ident: bib20
  article-title: The Interleukin 33/ST2 axis in patients with primary Sjogren syndrome: expression in serum and salivary glands and the clinical association
  publication-title: J. Rheumatol.
– volume: 22
  start-page: 7538
  year: 2021
  ident: bib10
  article-title: IgA vasculitis: etiology, treatment, biomarkers and epigenetic changes
  publication-title: Int. J. Mol. Sci.
– volume: 9
  start-page: 191
  year: 2001
  end-page: 196
  ident: bib41
  article-title: A single mutated MEFV allele in Israeli patients suffering from Familial Mediterranean Fever and Behcet's disease (FMF-BD)
  publication-title: Eur. J. Hum. Genet.
– volume: 10
  start-page: 6687
  year: 2021
  end-page: 6693
  ident: bib13
  article-title: The changes in pyroptosis-related inflammatory factors in the peripheral blood of patients with Henoch-Schonlein purpura
  publication-title: Ann. Palliat. Med.
– volume: 32
  start-page: 3785
  year: 2012
  end-page: 3792
  ident: bib8
  article-title: Investigation of the change in CD4
  publication-title: Rheumatol. Int.
– volume: 25
  start-page: 517
  year: 2017
  end-page: 521
  ident: bib7
  article-title: IL-33 and sST2 levels in serum of children with henoch- Schönlein purpura and their clinical significance
  publication-title: Zhongguo Shi Yan Xue Ye Xue Za Zhi
– volume: 16
  start-page: 1246
  year: 2017
  end-page: 1253
  ident: bib27
  article-title: New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)
  publication-title: Autoimmun. Rev.
– volume: 25
  start-page: 2077
  year: 2010
  end-page: 2082
  ident: bib23
  article-title: MEFV E148Q polymorphism is associated with Henoch-Schönlein purpura in Chinese children
  publication-title: Pediatr. Nephrol.
– volume: 10
  start-page: 103
  year: 2010
  end-page: 110
  ident: bib49
  article-title: Disease-associated functions of IL-33: the new kid in the IL-1 family
  publication-title: Nat. Rev. Immunol.
– volume: 114
  start-page: 3117
  year: 2009
  end-page: 3126
  ident: bib52
  article-title: Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
  publication-title: Blood
– volume: 12
  year: 2017
  ident: bib12
  article-title: HSPrognosis group, Biomarkers of IgA vasculitis nephritis in children
  publication-title: PLoS One
– volume: 54
  start-page: 77
  year: 1990
  end-page: 79
  ident: bib2
  article-title: Henoch-Schönlein purpura and IgA nephropathy in father and son
  publication-title: Nephron
– volume: 38
  start-page: 1947
  year: 2019
  end-page: 1952
  ident: bib29
  article-title: MEFV gene mutations in children with Henoch-Schonlein purpura and their correlations-do mutations matter?
  publication-title: Clin. Rheumatol.
– volume: 13
  year: 2022
  ident: bib3
  article-title: IgA vasculitis update: epidemiology, pathogenesis, and biomarkers
  publication-title: Front. Immunol.
– volume: 16
  start-page: 439
  year: 2014
  ident: bib39
  article-title: Genotypephenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations
  publication-title: Arthritis Res. Ther.
– volume: 131
  start-page: 68
  year: 2019
  end-page: 72
  ident: bib28
  article-title: MEFV gene variants in children with Henoch-Schonlein purpura and association with clinical manifestations: a single-center Mediterranean experience
  publication-title: Postgrad. Med.
– volume: 42
  start-page: 1005
  year: 2015
  end-page: 1019
  ident: bib14
  article-title: Interleukin-33 in tissue homeostasis, injury, and inflammation
  publication-title: Immunity
– volume: 27
  start-page: 519
  year: 2009
  end-page: 550
  ident: bib47
  article-title: Immunological and inflammatory functions of the interleukin-1 family
  publication-title: Annu. Rev. Immunol.
– volume: 2014
  year: 2014
  ident: bib60
  article-title: Interleukin-33 and inflammatory bowel diseases: lessons from human studies
  publication-title: Mediat. Inflamm.
– volume: 19
  start-page: 409
  year: 2019
  ident: bib9
  article-title: Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children
  publication-title: BMC Pediatr.
– volume: 9
  start-page: 2004
  year: 2018
  ident: bib57
  article-title: Regulatory mechanisms of IL-33-ST2 mediated allergic inflammation
  publication-title: Front. Immunol.
– volume: 17
  start-page: 25
  year: 1997
  end-page: 31
  ident: bib4
  article-title: A candidate gene for familial Mediterranean fever
  publication-title: Nat. Genet.
– volume: 103
  year: 2019
  ident: bib42
  article-title: Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review
  publication-title: J. Autoimmun.
– volume: 26
  start-page: 615
  year: 2015
  end-page: 623
  ident: bib50
  article-title: The IL-33/ST2 axis: role in health and disease
  publication-title: Cytokine Growth Factor Rev.
– volume: 183
  start-page: 5094
  year: 2009
  end-page: 5103
  ident: bib58
  article-title: Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells
  publication-title: J. Immunol.
– volume: 23
  start-page: 1
  year: 2018
  end-page: 16
  ident: bib56
  article-title: Interleukin-33: its emerging role in allergic diseases
  publication-title: Molecules
– volume: 16
  start-page: 347
  year: 2013
  end-page: 351
  ident: bib38
  article-title: MEFV gene mutations in Henoch- Schönlein purpura
  publication-title: Int J Rheum Dis
– volume: 12
  start-page: 41
  year: 2014
  ident: bib31
  article-title: MEFV gene mutations in Egyptjan children with Henoch-schonlein purpura
  publication-title: Pediatr. Rheumatol. Online J.
– volume: 69
  start-page: 1697
  year: 2010
  end-page: 1703
  ident: bib46
  article-title: IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
  publication-title: Ann. Rheum. Dis.
– volume: 70
  start-page: 171
  year: 2018
  end-page: 184
  ident: bib1
  article-title: Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides
  publication-title: Arthritis Rheumatol.
– volume: 12
  start-page: 22
  year: 2017
  end-page: 36
  ident: bib62
  article-title: Pathophysiology of IL-33 and IL-17 in allergic disorders
  publication-title: Cytokine Growth Factor Rev.
– volume: 46
  start-page: 967
  year: 2016
  end-page: 971
  ident: bib30
  article-title: MEFV gene in Ira nian Azari Turkish patients with Henoch-Schonlein purpura
  publication-title: Turk. J. Med. Sci.
– volume: 116
  start-page: e385
  year: 2018
  end-page: e391
  ident: bib32
  article-title: MEFV gene mutations and clinical course in pediatric patients with Henoch-Schönlein purpura
  publication-title: Arch. Argent. Pediatr.
– volume: 12
  start-page: 871
  year: 2021
  ident: bib44
  article-title: A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis
  publication-title: Cell Death Dis.
– volume: 71
  start-page: 101
  year: 2012
  end-page: 104
  ident: bib17
  article-title: IL-33: a Janus cytokine
  publication-title: Ann. Rheum. Dis.
– volume: 50
  start-page: 60
  year: 2019
  end-page: 74
  ident: bib63
  article-title: The role of the IL-33/ST2 axis in autoimmune disorders: friend or foe?
  publication-title: Cytokine Growth Factor Rev.
– volume: 61
  start-page: 84
  year: 2012
  end-page: 87
  ident: bib36
  article-title: MEFV gene mutations (M694V, V726A, M680I, and A744S) in Iranian children with Henoch-Schonlein purpura
  publication-title: Pneumologia
– volume: 23
  start-page: 479
  year: 2005
  end-page: 490
  ident: bib15
  article-title: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
  publication-title: Immunity
– volume: 29
  start-page: 241
  year: 2001
  end-page: 242
  ident: bib5
  article-title: A fever gene comes in from the cold
  publication-title: Nat. Genet.
– volume: 8
  start-page: 16000
  year: 2015
  end-page: 16006
  ident: bib45
  article-title: Serum Interleukin-33 level in Saudi children with inflammatory bowel disease
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 37
  start-page: 455
  year: 2017
  end-page: 460
  ident: bib24
  article-title: The association between MEFV gene polymorphisms and Henoch-Schönlein purpura, and additional SNP-SNP interactions in Chinese Han children
  publication-title: Rheumatol. Int.
– volume: 143
  start-page: 658
  year: 2003
  end-page: 661
  ident: bib37
  article-title: Prevalence and significance of mutation in familial Mediterranean fever gene in Henoch-Schönlein purpura
  publication-title: J. Pediatr.
– volume: 142
  start-page: 381
  year: 2018
  end-page: 393
  ident: bib54
  article-title: Mast cells signal their importance in health and disease
  publication-title: J. Allergy Clin. Immunol.
– volume: 15
  start-page: 385
  year: 2000
  end-page: 386
  ident: bib33
  article-title: The E148Q mutation in the MEFV gene: is it a diseasecausing mutation or a sequence variant?
  publication-title: Hum. Mutat.
– volume: 26
  start-page: 1091
  year: 2008
  end-page: 1094
  ident: bib34
  article-title: MEFV mutations in Japanese rheumatoid arthritis patients
  publication-title: Clin. Exp. Rheumatol.
– volume: 3
  start-page: 82
  year: 2012
  ident: bib48
  article-title: Mast cells respond to cell injury through the recognition of IL-33
  publication-title: Front. Immunol.
– volume: 98
  start-page: 15
  year: 2015
  end-page: 22
  ident: bib61
  article-title: The potential role of IL-33/ST2 signaling in fifibrotic diseases
  publication-title: J. Leukoc. Biol.
– volume: 8
  year: 2023
  ident: bib40
  article-title: A dominant pathogenic MEFV mutation causes atypical pyrin-associated periodic syndromes
  publication-title: JCI Insight
– volume: 43
  start-page: 729
  year: 2021
  end-page: 738
  ident: bib26
  article-title: IgA vasculitis
  publication-title: Semin. Immunopathol.
– volume: 113
  start-page: 8765
  year: 2016
  end-page: 8770
  ident: bib55
  article-title: Alternative splicing of interleukin-33 and type 2 inflflammation in asthma
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 76
  start-page: 260
  year: 2009
  end-page: 264
  ident: bib35
  article-title: Clinical significance of MEFV mutations in ankylosing spondylitis
  publication-title: Joint Bone Spine
– volume: 37
  start-page: 2006
  year: 2010
  end-page: 2013
  ident: bib59
  article-title: Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis
  publication-title: J. Rheumatol.
– volume: 31
  start-page: 1263
  year: 2011
  end-page: 1274
  ident: bib6
  article-title: Coexistence of vasculitides with familial Mediterranean fever
  publication-title: Rheumatol. Int.
– volume: 60
  start-page: 1151
  year: 2012
  end-page: 1156
  ident: bib18
  article-title: IL-33: a potential therapeutic target in autoimmune diseases
  publication-title: J. Invest. Med.
– volume: 202
  start-page: 46
  year: 2023
  end-page: 61
  ident: bib43
  article-title: Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS)-NRF2-Heme oxygenase-1(HO-1)-NF-кB axis
  publication-title: Free Radic. Biol. Med.
– volume: 29
  start-page: 241
  year: 2001
  ident: 10.1016/j.heliyon.2024.e29469_bib5
  article-title: A fever gene comes in from the cold
  publication-title: Nat. Genet.
  doi: 10.1038/ng1101-241
– volume: 9
  start-page: 191
  year: 2001
  ident: 10.1016/j.heliyon.2024.e29469_bib41
  article-title: A single mutated MEFV allele in Israeli patients suffering from Familial Mediterranean Fever and Behcet's disease (FMF-BD)
  publication-title: Eur. J. Hum. Genet.
  doi: 10.1038/sj.ejhg.5200608
– volume: 37
  start-page: 455
  year: 2017
  ident: 10.1016/j.heliyon.2024.e29469_bib24
  article-title: The association between MEFV gene polymorphisms and Henoch-Schönlein purpura, and additional SNP-SNP interactions in Chinese Han children
  publication-title: Rheumatol. Int.
  doi: 10.1007/s00296-016-3596-y
– volume: 46
  start-page: 967
  year: 2016
  ident: 10.1016/j.heliyon.2024.e29469_bib30
  article-title: MEFV gene in Ira nian Azari Turkish patients with Henoch-Schonlein purpura
  publication-title: Turk. J. Med. Sci.
  doi: 10.3906/sag-1505-131
– volume: 57
  start-page: 642
  year: 2012
  ident: 10.1016/j.heliyon.2024.e29469_bib11
  article-title: Inflammasomes in liver diseases
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2012.03.035
– volume: 116
  start-page: e385
  year: 2018
  ident: 10.1016/j.heliyon.2024.e29469_bib32
  article-title: MEFV gene mutations and clinical course in pediatric patients with Henoch-Schönlein purpura
  publication-title: Arch. Argent. Pediatr.
– volume: 69
  start-page: 1697
  year: 2010
  ident: 10.1016/j.heliyon.2024.e29469_bib46
  article-title: IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/ard.2009.122655
– volume: 22
  start-page: 7538
  year: 2021
  ident: 10.1016/j.heliyon.2024.e29469_bib10
  article-title: IgA vasculitis: etiology, treatment, biomarkers and epigenetic changes
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22147538
– volume: 12
  start-page: 871
  year: 2021
  ident: 10.1016/j.heliyon.2024.e29469_bib44
  article-title: A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-04159-9
– volume: 17
  start-page: 25
  year: 1997
  ident: 10.1016/j.heliyon.2024.e29469_bib4
  article-title: A candidate gene for familial Mediterranean fever
  publication-title: Nat. Genet.
  doi: 10.1038/ng0997-25
– volume: 61
  start-page: 84
  year: 2012
  ident: 10.1016/j.heliyon.2024.e29469_bib36
  article-title: MEFV gene mutations (M694V, V726A, M680I, and A744S) in Iranian children with Henoch-Schonlein purpura
  publication-title: Pneumologia
– volume: 16
  start-page: 1246
  year: 2017
  ident: 10.1016/j.heliyon.2024.e29469_bib27
  article-title: New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2017.10.009
– volume: 54
  start-page: 77
  year: 1990
  ident: 10.1016/j.heliyon.2024.e29469_bib2
  article-title: Henoch-Schönlein purpura and IgA nephropathy in father and son
  publication-title: Nephron
  doi: 10.1159/000185813
– volume: 113
  start-page: 8765
  year: 2016
  ident: 10.1016/j.heliyon.2024.e29469_bib55
  article-title: Alternative splicing of interleukin-33 and type 2 inflflammation in asthma
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1601914113
– volume: 13
  year: 2022
  ident: 10.1016/j.heliyon.2024.e29469_bib3
  article-title: IgA vasculitis update: epidemiology, pathogenesis, and biomarkers
  publication-title: Front. Immunol.
– volume: 305
  start-page: 173
  year: 2013
  ident: 10.1016/j.heliyon.2024.e29469_bib51
  article-title: Elevated serum interleukin-33 levels in patients with Henoch-Schonlein purpura
  publication-title: Arch. Dermatol. Res.
  doi: 10.1007/s00403-012-1268-7
– volume: 202
  start-page: 46
  year: 2023
  ident: 10.1016/j.heliyon.2024.e29469_bib43
  article-title: Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS)-NRF2-Heme oxygenase-1(HO-1)-NF-кB axis
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2023.03.024
– volume: 112
  start-page: 4056
  year: 2015
  ident: 10.1016/j.heliyon.2024.e29469_bib53
  article-title: T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1418549112
– volume: 25
  start-page: 517
  year: 2017
  ident: 10.1016/j.heliyon.2024.e29469_bib7
  article-title: IL-33 and sST2 levels in serum of children with henoch- Schönlein purpura and their clinical significance
  publication-title: Zhongguo Shi Yan Xue Ye Xue Za Zhi
– volume: 143
  start-page: 658
  year: 2003
  ident: 10.1016/j.heliyon.2024.e29469_bib37
  article-title: Prevalence and significance of mutation in familial Mediterranean fever gene in Henoch-Schönlein purpura
  publication-title: J. Pediatr.
  doi: 10.1067/S0022-3476(03)00502-X
– volume: 507
  start-page: 75
  year: 2020
  ident: 10.1016/j.heliyon.2024.e29469_bib16
  article-title: Soluble ST2: a complex and diverse role in several diseases
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2020.04.011
– volume: 60
  start-page: 1151
  year: 2012
  ident: 10.1016/j.heliyon.2024.e29469_bib18
  article-title: IL-33: a potential therapeutic target in autoimmune diseases
  publication-title: J. Invest. Med.
  doi: 10.2310/JIM.0b013e31826d8fcb
– volume: 35
  start-page: 2427
  year: 2008
  ident: 10.1016/j.heliyon.2024.e29469_bib21
  article-title: MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura
  publication-title: J. Rheumatol.
  doi: 10.3899/jrheum.080405
– volume: 32
  start-page: 3785
  year: 2012
  ident: 10.1016/j.heliyon.2024.e29469_bib8
  article-title: Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein purpura
  publication-title: Rheumatol. Int.
  doi: 10.1007/s00296-011-2266-3
– volume: 23
  start-page: 479
  year: 2005
  ident: 10.1016/j.heliyon.2024.e29469_bib15
  article-title: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.09.015
– volume: 25
  start-page: 2077
  year: 2010
  ident: 10.1016/j.heliyon.2024.e29469_bib23
  article-title: MEFV E148Q polymorphism is associated with Henoch-Schönlein purpura in Chinese children
  publication-title: Pediatr. Nephrol.
  doi: 10.1007/s00467-010-1582-2
– volume: 3
  start-page: 82
  year: 2012
  ident: 10.1016/j.heliyon.2024.e29469_bib48
  article-title: Mast cells respond to cell injury through the recognition of IL-33
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2012.00082
– volume: 8
  year: 2023
  ident: 10.1016/j.heliyon.2024.e29469_bib40
  article-title: A dominant pathogenic MEFV mutation causes atypical pyrin-associated periodic syndromes
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.172975
– volume: 10
  start-page: 6687
  year: 2021
  ident: 10.1016/j.heliyon.2024.e29469_bib13
  article-title: The changes in pyroptosis-related inflammatory factors in the peripheral blood of patients with Henoch-Schonlein purpura
  publication-title: Ann. Palliat. Med.
  doi: 10.21037/apm-21-1227
– volume: 16
  start-page: 347
  year: 2013
  ident: 10.1016/j.heliyon.2024.e29469_bib38
  article-title: MEFV gene mutations in Henoch- Schönlein purpura
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.12072
– volume: 183
  start-page: 5094
  year: 2009
  ident: 10.1016/j.heliyon.2024.e29469_bib58
  article-title: Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0802387
– volume: 8
  start-page: 16000
  year: 2015
  ident: 10.1016/j.heliyon.2024.e29469_bib45
  article-title: Serum Interleukin-33 level in Saudi children with inflammatory bowel disease
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 98
  start-page: 15
  year: 2015
  ident: 10.1016/j.heliyon.2024.e29469_bib61
  article-title: The potential role of IL-33/ST2 signaling in fifibrotic diseases
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.3RU0115-012R
– volume: 42
  start-page: 1005
  year: 2015
  ident: 10.1016/j.heliyon.2024.e29469_bib14
  article-title: Interleukin-33 in tissue homeostasis, injury, and inflammation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.06.006
– volume: 26
  start-page: 615
  year: 2015
  ident: 10.1016/j.heliyon.2024.e29469_bib50
  article-title: The IL-33/ST2 axis: role in health and disease
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2015.07.017
– volume: 114
  start-page: 3117
  year: 2009
  ident: 10.1016/j.heliyon.2024.e29469_bib52
  article-title: Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
  publication-title: Blood
  doi: 10.1182/blood-2009-02-203372
– volume: 100
  start-page: 745
  year: 2011
  ident: 10.1016/j.heliyon.2024.e29469_bib22
  article-title: Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Schönlein purpura
  publication-title: Acta. Pediatr.
  doi: 10.1111/j.1651-2227.2011.02143.x
– volume: 65
  start-page: 936
  year: 2006
  ident: 10.1016/j.heliyon.2024.e29469_bib25
  article-title: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides
  publication-title: Annals of the rheumatic dieases
  doi: 10.1136/ard.2005.046300
– volume: 26
  start-page: 1091
  year: 2008
  ident: 10.1016/j.heliyon.2024.e29469_bib34
  article-title: MEFV mutations in Japanese rheumatoid arthritis patients
  publication-title: Clin. Exp. Rheumatol.
– volume: 70
  start-page: 171
  year: 2018
  ident: 10.1016/j.heliyon.2024.e29469_bib1
  article-title: Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides
  publication-title: Arthritis Rheumatol.
  doi: 10.1002/art.40375
– volume: 42
  start-page: 264
  year: 2015
  ident: 10.1016/j.heliyon.2024.e29469_bib20
  article-title: The Interleukin 33/ST2 axis in patients with primary Sjogren syndrome: expression in serum and salivary glands and the clinical association
  publication-title: J. Rheumatol.
  doi: 10.3899/jrheum.140234
– volume: 38
  start-page: 1947
  year: 2019
  ident: 10.1016/j.heliyon.2024.e29469_bib29
  article-title: MEFV gene mutations in children with Henoch-Schonlein purpura and their correlations-do mutations matter?
  publication-title: Clin. Rheumatol.
  doi: 10.1007/s10067-019-04489-2
– volume: 12
  start-page: 41
  year: 2014
  ident: 10.1016/j.heliyon.2024.e29469_bib31
  article-title: MEFV gene mutations in Egyptjan children with Henoch-schonlein purpura
  publication-title: Pediatr. Rheumatol. Online J.
  doi: 10.1186/1546-0096-12-41
– volume: 16
  start-page: 439
  year: 2014
  ident: 10.1016/j.heliyon.2024.e29469_bib39
  article-title: Genotypephenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations
  publication-title: Arthritis Res. Ther.
  doi: 10.1186/s13075-014-0439-7
– volume: 19
  start-page: 409
  year: 2019
  ident: 10.1016/j.heliyon.2024.e29469_bib9
  article-title: Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children
  publication-title: BMC Pediatr.
  doi: 10.1186/s12887-019-1802-2
– volume: 10
  start-page: 103
  year: 2010
  ident: 10.1016/j.heliyon.2024.e29469_bib49
  article-title: Disease-associated functions of IL-33: the new kid in the IL-1 family
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2692
– volume: 71
  start-page: 101
  year: 2012
  ident: 10.1016/j.heliyon.2024.e29469_bib17
  article-title: IL-33: a Janus cytokine
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2011-200589
– volume: 37
  start-page: 2006
  year: 2010
  ident: 10.1016/j.heliyon.2024.e29469_bib59
  article-title: Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis
  publication-title: J. Rheumatol.
  doi: 10.3899/jrheum.100184
– volume: 131
  start-page: 68
  year: 2019
  ident: 10.1016/j.heliyon.2024.e29469_bib28
  article-title: MEFV gene variants in children with Henoch-Schonlein purpura and association with clinical manifestations: a single-center Mediterranean experience
  publication-title: Postgrad. Med.
  doi: 10.1080/00325481.2019.1552479
– volume: 12
  year: 2017
  ident: 10.1016/j.heliyon.2024.e29469_bib12
  article-title: HSPrognosis group, Biomarkers of IgA vasculitis nephritis in children
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0188718
– volume: 43
  start-page: 729
  year: 2021
  ident: 10.1016/j.heliyon.2024.e29469_bib26
  article-title: IgA vasculitis
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-021-00874-9
– volume: 2014
  year: 2014
  ident: 10.1016/j.heliyon.2024.e29469_bib60
  article-title: Interleukin-33 and inflammatory bowel diseases: lessons from human studies
  publication-title: Mediat. Inflamm.
  doi: 10.1155/2014/423957
– volume: 27
  start-page: 519
  year: 2009
  ident: 10.1016/j.heliyon.2024.e29469_bib47
  article-title: Immunological and inflammatory functions of the interleukin-1 family
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.021908.132612
– volume: 103
  year: 2019
  ident: 10.1016/j.heliyon.2024.e29469_bib42
  article-title: Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2019.06.010
– volume: 73
  start-page: 1259
  year: 2014
  ident: 10.1016/j.heliyon.2024.e29469_bib19
  article-title: Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2012-203187
– volume: 23
  start-page: 1
  year: 2018
  ident: 10.1016/j.heliyon.2024.e29469_bib56
  article-title: Interleukin-33: its emerging role in allergic diseases
  publication-title: Molecules
  doi: 10.3390/molecules23071665
– volume: 50
  start-page: 60
  year: 2019
  ident: 10.1016/j.heliyon.2024.e29469_bib63
  article-title: The role of the IL-33/ST2 axis in autoimmune disorders: friend or foe?
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2019.04.004
– volume: 142
  start-page: 381
  year: 2018
  ident: 10.1016/j.heliyon.2024.e29469_bib54
  article-title: Mast cells signal their importance in health and disease
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2018.01.034
– volume: 12
  start-page: 22
  year: 2017
  ident: 10.1016/j.heliyon.2024.e29469_bib62
  article-title: Pathophysiology of IL-33 and IL-17 in allergic disorders
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2017.09.005
– volume: 31
  start-page: 1263
  year: 2011
  ident: 10.1016/j.heliyon.2024.e29469_bib6
  article-title: Coexistence of vasculitides with familial Mediterranean fever
  publication-title: Rheumatol. Int.
  doi: 10.1007/s00296-011-1840-z
– volume: 76
  start-page: 260
  year: 2009
  ident: 10.1016/j.heliyon.2024.e29469_bib35
  article-title: Clinical significance of MEFV mutations in ankylosing spondylitis
  publication-title: Joint Bone Spine
  doi: 10.1016/j.jbspin.2008.09.011
– volume: 15
  start-page: 385
  year: 2000
  ident: 10.1016/j.heliyon.2024.e29469_bib33
  article-title: The E148Q mutation in the MEFV gene: is it a diseasecausing mutation or a sequence variant?
  publication-title: Hum. Mutat.
  doi: 10.1002/(SICI)1098-1004(200004)15:4<385::AID-HUMU22>3.0.CO;2-A
– volume: 9
  start-page: 2004
  year: 2018
  ident: 10.1016/j.heliyon.2024.e29469_bib57
  article-title: Regulatory mechanisms of IL-33-ST2 mediated allergic inflammation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.02004
SSID ssj0001586973
Score 2.265824
Snippet Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its pathogenesis is still...
Objective: Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children. HSP is a multifactorial inflammatory disease, but its...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e29469
SubjectTerms alleles
C-reactive protein
Children
exons
familial Mediterranean fever
Henoch-Schönlein purpura
hospitals
Interleukin-33
MEFV
pathogenesis
pathogenicity
physical health
regression analysis
risk
Soluble ST2
vasculitis
Title Associations of MEFV gene variants, IL-33, and sST2 with the risk of Henoch-Schönlein purpura in children
URI https://dx.doi.org/10.1016/j.heliyon.2024.e29469
https://www.ncbi.nlm.nih.gov/pubmed/38655333
https://www.proquest.com/docview/3046517703
https://www.proquest.com/docview/3153834141
https://pubmed.ncbi.nlm.nih.gov/PMC11036003
https://doaj.org/article/908cdf1792cc42ff97b58aff91d8f6dd
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkRAXxJvlURmJY7PdxHacHAvqaqEsB9pCb5af2l1VTtXtIvHH-AP8MWbipGRBohdOiRI7iWfGnm8y4xlC3gTLjLSVyZyTOuOy8Fmlhc8Y0wYmpjC6rdYw_1TOTvmHM3E2KPWFMWEpPXAi3H49qawLIDaFtbwIoZZGVBqOuatC6RyuvpN6MjCm0v7gqqwl-71lZ381Xvjz5fcGc54WfOyLmmOQ80AZtTn7t3TS35jzz9DJgS6a3if3OhBJD9LHPyC3fHxI7sw7N_kjshoQfU2bQOeH0y8URMXTb2AbY-jLHn3_EUi1R3V0dH18UlD8I0sBDlKMNsdOMx8bu8iO7eLnj3jul5FeAFc2l5rCab8J_DE5nR6evJtlXVGFzHL0pgAgFM4JHzgYe4JpaTGjlwMaMw0Ln9TlhMtQcKmdLJ2vg2PG2MI5HpipwfR-QnZiE_0zQj03peWhcDY3nJvcaGe0BowhayOMNyMy7qmrLlLuDNUHla1Uxw6F7FCJHSPyFnlw3RhTX7cXQCBUJxDqJoEYkarnoOpQREIH8KjlTe9_3XNcwSxD14mOvtmsFfqPRS5hefxHG1QeAAp4PiJPk5RcjwQrqwKwht7VlvxsDXX7Tlwu2mzfgM8YoFL2_H8Q5wW5i-NN7rCXZOfqcuNfAaq6Mrvk9sHR569Hu-1E-gX8pibn
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Associations+of+MEFV+gene+variants%2C+IL-33%2C+and+sST2+with+the+risk+of+Henoch-Sch%C3%B6nlein+purpura+in+children&rft.jtitle=Heliyon&rft.au=Ruan%2C+Yang&rft.au=Xie%2C+Longlong&rft.date=2024-04-30&rft.issn=2405-8440&rft.eissn=2405-8440&rft.volume=10&rft.issue=8+p.e29469-&rft_id=info:doi/10.1016%2Fj.heliyon.2024.e29469&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon